Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia

Blood

Volumn 100, Issue 4, 2002, Pages 1449-1453

  Liu, Jin Hong ^a,b   Wei, Sheng ^a,b   Lamy, Thierry ^a,b   Li, Yongxiang ^a,b   Epling Burnette, P K ^a,b   Djeu, Julie Y ^a,b   Loughran Jr , Thomas P ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; RNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC RESISTANCE; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LARGE GRANULAR LYMPHOCYTE; LEUKEMIA; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; RNA ANALYSIS; SERUM; SIGNAL TRANSDUCTION; SYNDROME DELINEATION;

EID: 0037103302     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.4.1449.h81602001449_1449_1453     Document Type: Article

References (28)

1. Contenders in FasL/TNF death signaling
2. Fas and FasL in the homeostatic regulation of immune responses
3. Role of Fas-mediated cell death in the regulation of immune responses
4. Die and let live: Eliminating dangerous lymphocytes
5. Apoptosis in the pathogenesis and treatment of disease
6. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
7. The Fas death factor
8. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells
9. Expression of the functional soluble form of human fas ligand in activated lymphocytes
10. Expression of the Fas ligand in cells of T cell lineage
11. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
12. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
13. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
14. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders
15. Fas and Fas ligand: Ipr and gld mutations
16. Clonal diseases of large granular lymphocytes
17. Lectin-dependent anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen
18. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice
19. + large granular lymphocyte leukemia
20. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
21. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
22. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
23. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing
24. Fas splicing variants and their effect on apoptosis
25. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro
26. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias
27. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis
28. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-l expression